TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05488431: Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

Sponsor: Priscilla Hsue, MD · Phase: PHASE2 · Area: INFECTIOUS_VACCINE · Target Enrollment: 121 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$7,467,600

Rescue Site Savings

+$4,939,200

Unlock Full NCT05488431 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05488431 Rescue Dossier →